← Leaderboards
Andres Obregon
State University Of New York At Buffalo
$1,173,856
Attributed
$2,347,712
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $955.1K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,347,712 · 2
By mechanism
R61$1,392,562 · 1
R33$955,150 · 1
Top collaborators
- Jonathan F Lovell4 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Jonathan F Lovell$9,226,863
- Jean-Philippe Julien$1,339,335
- Madhavan P Nair$24,745,414
- Glenna C L Bett$2,312,232
Others in their field
Other Rising Stars on “Adjuvant”
- Warwick Britton · University Of Sydney$10,964,476
- Philip Felgner · University Of California-Irvine$10,234,165
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Li Liang · University Of California-Irvine$7,511,446
- Bruxanne El-Kammash · University Of Chicago$7,281,050
- Nicolas Collins · Vaccine Formulation Institute (Ch) Ltd$6,937,118
Research focus
AdjuvantFormulationAerosolsAntigensAnimal ModelBacille Calmette-Guerin VaccinationAntigen-Presenting CellsBcg LiveBenchmarkingBindingAntigen-Specific T CellsBiologicalC3heb/Fej MouseCaviaCellsCobaltComparative EfficacyCovid-19 VaccineDensityDesignDoseDraining Lymph NodeBiochemicalFreeze Drying
Grant awards (4)
Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis$955,150
R33 · FY2025 · AI
Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis$452,970
R61 · FY2024 · AI
Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis$458,723
R61 · FY2023 · AI
Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis$480,869
R61 · FY2022 · AI